Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
Crossref DOI link: https://doi.org/10.1136/bmj.l4772
Published Online: 2019-08-29
Update policy: https://doi.org/10.1136/crossmarkpolicy
Pasternak, Björn http://orcid.org/0000-0002-2097-8466
Ueda, Peter
Eliasson, Björn
Svensson, Ann-Marie
Franzén, Stefan
Gudbjörnsdottir, Soffia
Hveem, Kristian
Jonasson, Christian
Wintzell, Viktor
Melbye, Mads
Svanström, Henrik
Text and Data Mining valid from 2019-08-29